Viridian Therapeutics, Inc.\DE VRDN Cash Flow Statement (2013-2026)

NASDAQ VRDN
$23.19 +0.18 (+0.78%)
As of: Oct 22, 2026 · 11:38 AM EDT
Reported Financials

Viridian Therapeutics, Inc.\DE Quarterly Cash Flow Statement

Periods 53 quarters
Latest Jun 2026

Viridian Therapeutics, Inc.\DE reported cash from operations of -$105.32M and free cash flow of -$106.63M for the quarter ended Jun 2026, down 39.7% year over year. This cash flow statement covers 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.04M-28.95M-25.69M-29.49M-28.91M-45.79M-68.15M-55.06M-47.66M-66.86M-48.54M-64.99M-76.69M-79.73M-86.91M-100.74M-34.60M-120.36M-104.90M-127.12M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.09M0.05M0.05M0.13M0.05M0.05M0.09M0.12M0.12M0.12M0.07M0.06M0.10M0.10M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.03M0.04M0.06M0.06M0.14M0.11M0.13M0.14M0.15M0.15M0.14M0.13M0.12M0.12M0.11M0.11M0.16M0.12M0.12M
Share-based CompensationStock Comp.
3.98M3.49M4.66M4.89M4.94M5.28M15.22M12.30M13.61M26.05M12.69M11.77M8.72M8.98M10.22M10.84M11.25M11.99M13.39M16.98M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
-0.01M0.00M0.00M
Gains from Investment SecuritiesGains Investment
0.01M7.53M-1.19M
Other non-cash itemsOther Non-Cash
1.00M0.10M0.05M0.00M0.00M0.00M0.04M-0.04M0.78M0.31M-0.02M0.18M0.34M0.49M0.10M0.09M0.09M2.45M2.51M6.79M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
1.46M-1.41M0.03M1.70M8.05M1.75M-6.65M-3.77M-0.11M-1.52M0.48M0.44M2.93M-3.92M1.77M4.63M1.55M-1.38M4.63M-5.20M
Change in Accured ExpensesChange Accured Exp.
-5.93M1.63M0.48M5.48M-4.25M6.00M2.58M2.64M-5.03M4.53M-0.89M7.53M3.91M10.79M-15.91M6.18M4.61M21.32M-23.69M6.11M
Change in Other Operating AssetsOther Assets Change
-1.45M-0.81M0.81M0.95M0.81M0.42M2.12M3.50M-1.13M-2.38M4.47M-3.23M4.01M6.41M-0.29M-5.19M66.63M-61.41M2.33M2.40M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M
Other Working Capital ChangesOther WC Changes
1.38M0.74M-0.88M-1.02M-0.88M-0.49M-2.19M-3.57M1.06M2.31M-4.55M3.16M-4.08M-6.48M0.21M5.12M-66.63M61.41M-2.33M-2.40M
Cash from OperationsCash from Ops.
-11.88M-16.54M-21.04M-18.09M-20.67M-34.04M-61.97M-45.21M-38.98M-38.00M-45.22M-46.06M-67.71M-73.33M-92.65M-75.37M-84.61M-23.75M-119.65M-105.32M
Investing Activities
Capital ExpendituresCapex
0.19M0.08M0.18M0.29M0.10M0.23M0.12M0.33M0.40M0.05M0.10M0.29M0.11M0.09M0.04M0.13M0.24M0.02M1.31M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.18M-0.08M-0.18M-0.29M-0.10M-0.23M-0.12M-0.33M-0.40M-0.05M-0.10M-0.29M-0.11M-0.09M-0.04M-0.13M-0.24M-0.02M-1.31M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
18.17M102.88M5.19M218.07M77.28M8.06M50.05M272.50M225.61M59.26M228.42M181.78M71.24M55.76M14.09M438.19M91.32M378.66M
Sale and Maturity of InvestmentsInvestments Sold
45.51M28.47M28.51M42.75M37.70M64.10M49.10M98.49M102.83M82.56M121.34M144.05M118.98M171.39M131.52M140.29M99.01M168.60M148.80M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
6.25M-80.21M8.86M13.96M42.65M-180.60M-13.30M40.71M48.04M-169.71M-143.05M61.98M-84.67M-62.92M100.06M75.72M126.08M-339.42M77.26M-231.16M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.45M15.00M
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
0.45M15.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.45M15.00M
Change in Capital Stock
Common Stock IssuedStock Issued
105.99M2.07M0.74M0.00M268.07M26.94M8.20M3.07M0.97M134.55M1.19M0.21M421.44M36.83M9.42M0.76M11.07M345.74M6.36M145.60M
Net Shares Issued and RepurchasedNet Shares Issued
105.99M2.07M0.74M0.00M268.07M26.94M8.20M3.07M0.97M134.55M1.19M0.21M421.44M36.83M9.42M0.76M11.07M345.74M6.36M145.60M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
76.19M
Net Equity Issued and RepurchasedNet Equity Issued
105.99M2.07M0.74M0.00M268.07M26.94M8.20M3.07M0.97M210.74M1.19M0.21M421.44M36.83M9.42M0.76M11.07M345.74M6.36M145.60M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
Dividends Paid - Common and PrefferdDiv Paid (Total)
Other financing activitiesOther financing
-6.16M6.38M-0.45M-0.51M-10.38M-0.10M10.48M-0.21M-0.21M-0.06M-15.78M
Cash from Financing ActivitiesCash from Financing
116.79M0.17M0.74M4.56M290.93M26.01M8.20M3.07M15.46M198.94M177.08M0.11M245.02M35.52M9.21M0.76M10.86M405.91M6.36M325.12M
Additional items
Change in Cash
111.17M-96.58M-11.44M0.44M312.92M-188.63M-67.06M-1.43M24.52M-8.77M-11.19M16.03M92.65M-100.72M16.62M1.11M52.32M42.74M-36.04M-11.36M
Ending Cash Balance
138.88M42.30M30.86M31.29M344.21M155.58M88.52M87.08M111.60M102.83M91.64M107.67M200.32M99.59M116.22M117.32M169.65M212.38M176.35M164.99M
Free Cash FlowFCF
-12.06M-16.62M-21.22M-18.38M-20.76M-34.27M-62.09M-45.55M-39.39M-38.05M-45.22M-46.16M-68.00M-73.45M-92.74M-75.42M-84.74M-23.99M-119.68M-106.63M
Net Cash FlowNCF
111.17M-96.58M-11.44M0.44M312.92M-188.63M-67.06M-1.43M24.52M-8.77M-11.19M16.03M92.65M-100.72M16.62M1.11M52.32M42.74M-36.04M-11.36M
Interest Paid
0.08M0.15M0.11M0.11M0.21M0.45M0.45M0.46M0.46M0.45M0.45M0.46M0.46M0.79M1.12M1.11M

Viridian Therapeutics, Inc.\DE Cash Flow Statement API

Pull Viridian Therapeutics, Inc.\DE's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRDN&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY